Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 409 - 416 of 12016 results
Mintz on Air: Predictions and Practical Policies – Workplace Whiplash
December 17, 2024| Podcast| Viewpoint
Dealmaking Dormant No More
December 17, 2024| News
How Johnson v. Parker-Hannifin Impacts Professional Fiduciaries And 401k Plan Sponsors
December 17, 2024| News
Key Takeaways from the OIG’s New Compliance Program Guidance for Skilled Nursing Facilities
December 16, 2024| Blog| Viewpoint
Feds’ Decision to Transfer $1.9B Public Pension Surplus to General Revenue Within Its Purview
December 16, 2024| News
Delaware’s Consumer Privacy Law is Right Around the Corner
December 13, 2024| Blog| Viewpoint
Trump Taps David Sacks as AI and Crypto Czar — AI: The Washington Report
December 12, 2024| Article| Viewpoint
Can a Consumer Plausibly Allege Your Product Labeling is False or Misleading Under California Law?
December 12, 2024| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|